# OnCo record torl-biotherapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/torl-biotherapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "torl-biotherapeutics" ;
  schema:name "TORL BioTherapeutics"@en ;
  schema:alternateName "TORL Biotherapeutics, LLC"@en ;
  schema:description "TORL BioTherapeutics is a US-based biotechnology company that leads 3 cancer trials in OnCo, testing the antibody-drug conjugates TORL-1-23 (ixotatug vedotin) and TORL-5-700 in non-Hodgkin lymphoma and ovarian cancer."@en ;
  schema:url <https://onco.cc/companies/torl-biotherapeutics/>, <https://torlbio.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://torlbio.com/>, <https://clinicaltrials.gov/search?lead=TORL%20Biotherapeutics%2C%20LLC> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/ovarian/> ;
  onco:drugs <https://onco.cc/drugs/pegfilgrastim/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/carboplatin/> ;
  onco:trials <https://onco.cc/trials/nct07439653/>, <https://onco.cc/trials/nct06690775/>, <https://onco.cc/trials/nct07322094/> .